Labetalol, nifedipine, hydralazine and methyldopa in pregnancy: nursing care

The usual agents and how they lower pressure

Labetalol blocks beta receptors and alpha receptors, lowering heart rate and vascular resistance. Nifedipine is a calcium channel blocker that relaxes arterial smooth muscle; extended-release forms allow once-daily dosing. Methyldopa acts centrally to reduce sympathetic outflow. Hydralazine is a direct arterial vasodilator used mainly intravenously for severe hypertension.

The goal differs from routine hypertension care. Blood pressure is lowered enough to protect the mother from stroke and organ damage, but not so far or so fast that uteroplacental blood flow falls. That balance shapes nearly every nursing decision on this page, including how often to check and what counts as a concerning drop.

Why ACE inhibitors and ARBs are avoided

Drugs acting on the renin-angiotensin system carry a boxed warning for fetal toxicity. Exposure in the second and third trimesters reduces fetal kidney function, leading to oligohydramnios, kidney failure, skull and lung underdevelopment and death. Aldosterone antagonists are also avoided. The label advises stopping these drugs as soon as pregnancy is detected.

For nurses this means two checks. In pregnancy, an order for an ACE inhibitor or ARB needs immediate clarification. Before pregnancy, people of childbearing potential taking these drugs need teaching to plan pregnancy with their prescriber and report a positive test promptly, so a switch can be made early.

Drug-specific monitoring and hold triggers

Labetalol is contraindicated in asthma or obstructive airway disease, heart block beyond first degree, severe bradycardia and overt heart failure, so check history, heart rate and breath sounds. After IV doses, postural hypotension is common: keep the patient lying down for the period the label specifies, and establish that they tolerate sitting before walking. Report wheeze or bradycardia.

Hydralazine can cause tachycardia, palpitations, headache and hypotension, with peak effect within minutes to over an hour after IV injection, so check blood pressure frequently. Methyldopa can cause drowsiness, depression and orthostatic hypotension. Labetalol crosses the placenta, and newborns may have low blood glucose, bradycardia or hypotension, which the neonatal team should know.

Remember that antihypertensives treat blood pressure, not the underlying pre-eclampsia process. A patient whose pressure is well controlled can still develop worsening laboratory results, seizures or placental problems. Continue assessing reflexes, urine output, symptoms and laboratory trends as ordered, and do not let a normal reading reassure you about the whole clinical picture.

Fetal assessment and teaching

A sudden fall in maternal blood pressure can abruptly reduce uteroplacental blood flow, so fetal heart rate monitoring often accompanies acute treatment under local protocol. Report a significant maternal drop, new fetal heart rate changes, or maternal symptoms such as dizziness or faintness. Beta blockers have been linked with fetal growth restriction, so growth surveillance may be planned.

Teach home blood pressure measurement where used, adherence, and rising slowly. Teach the warning signs that need urgent review regardless of medicine: severe headache, visual disturbance, upper abdominal pain, sudden swelling, breathlessness or reduced fetal movements. Explain that changing or stopping medicines needs the prescriber's input.

Worked scenario: after IV labetalol

A hypothetical patient at 34 weeks with severe hypertension receives IV labetalol and her pressure improves. Twenty minutes later she asks to walk to the bathroom; her heart rate is 58, she feels light-headed, and she has a history of childhood asthma. Options are to walk her with assistance, give a bedpan and reassess, or give the next ordered dose.

A bedpan and reassessment is the strongest response. Postural hypotension is common after IV labetalol, and light-headedness with a slow heart rate makes walking unsafe. Her asthma history and bradycardia should be reported before any further labetalol. Check fetal heart rate and blood pressure, keep her lying on her side and document.

Sources and further reading

MSD Manual Professional: Hypertension in pregnancy. Preferred agents, ACE inhibitor, ARB and aldosterone antagonist risks, methyldopa effects, beta blocker growth concern and placental flow.

DailyMed: Labetalol hydrochloride injection prescribing information. Contraindications, postural hypotension after IV use, placental transfer and neonatal effects.

DailyMed: Hydralazine hydrochloride injection prescribing information. Direct vasodilator action, tachycardia, headache, hypotension and timing of peak effect.

DailyMed: Lisinopril tablets prescribing information. Boxed fetal toxicity warning, oligohydramnios, fetal renal failure and stopping when pregnancy is detected.